Prelude Therapeutics to Participate in Barclays 27th Annual Global Healthcare Conference

WILMINGTON, Del., March 05, 2025 (GLOBE NEWSWIRE) -- Prelude Therapeutics Incorporated (Prelude) (Nasdaq: PRLD), a clinical-stage precision oncology company, announced today that the Company will participate in the Barclays 27^th Annual Global Healthcare Conference, taking place in Miami, FL on March 11, 2025.

Read more at globenewswire.com